Le Lézard
Classified in: Health
Subjects: SBS, MAT

FARMACEUTICALRX LLC of Pennsylvania Announces That it Received Full Certification to Operate its Pennsylvania Medical Marijuana Grower/Processor Operations


PITTSBURGH, Sept. 19, 2019 /PRNewswire/ -- FARMACEUTICALRX, a therapeutics company focused on the medical marijuana sector with a multi-state operational platform, today announced that it has received full certification to operate its Grower/Processor operations in Pennsylvania.  FARMACEUTICALRX was awarded a Grower/Processor license last summer from the Pennsylvania Medical Marijuana Office as part of Round Two of the Medical Marijuana Program. FARMACEUTICALRX's Grower/Processor facility, located in Farrell, PA, is a state-of-the-art facility designed to develop high-quality medical marijuana products for patients in Pennsylvania.  The Company commenced harvesting in August and projects that it will commence medical product sales in Pennsylvania in the coming weeks.

"We are excited to be the first Grower/Processor to be fully certified to operate in Pennsylvania in Round 2," stated Rebecca Myers, Founder and CEO of FARMACEUTICALRX.  "Our living soil cultivation, extraction, and high-quality focused product development platform is growing rapidly and Pennsylvania is a core component of our multi-state operations.  We will differentiate ourselves in the market with our living soil style of cultivation, our development of high quality therapeutics that include our inhouse derived terpenes and with the development of our leading brands," Myers commented. 

FARMACEUTICALRX is the first Phase II Grower/Processor to be fully certified to operate in Pennsylvania.

FARMACEUTICALRX is focused on advancing the knowledge base around medical marijuana therapies. The Company's formulation and branding engine is powered by multiple R&D relationships with premier academic centers held by its sister company. FARMACEUTICALRX is committed to offering the highest-quality products to patients in the Pennsylvania market.

ABOUT FARMACEUTICALRX.  FARMACEUTICALRX is a leading multi-state operator and therapeutics company focused on bringing innovations through research and development to the medical marijuana sector.  FARMACEUTICALRX has a vertically integrated multi-state operational platform.  FARMACEUTICALRX and its affiliated companies are licensed to offer high quality medical marijuana therapeutics to more than 26 million patients through its multi-state platform including Ohio and Pennsylvania.  FARMACEUTICALRX is led by a world-class team of scientists, healthcare and cannabis industry professionals who are driven by the discovery, development, and manufacturing of revolutionary, high quality products through its vertically integrated platform. Our innovation is your future health.  Learn more at www.farmaceuticalrx.com.

Media Contact:
Kyle Morse
407.919.9470
[email protected] 

SOURCE FARMACEUTICALRX


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: